Pulse Biosciences, Inc. (PLSE) Total liabilities 2020–2025
Pulse Biosciences, Inc. (PLSE) total liabilities at each fiscal year-end, per SEC filings.
$13.9MFY2025 · since FY2020: $18.4M → $13.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.9M | -21.1% |
| FY2024 | $17.6M | +19.0% |
| FY2023 | $14.8M | -81.5% |
| FY2022 | $80.1M | +441.6% |
| FY2021 | $14.8M | -19.6% |
| FY2020 | $18.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net incomePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating incomePLSE Operating marginPLSE Operating cash flowPLSE Free cash flowPLSE Capital expendituresPLSE Return on equityPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Shareholders’ equityPLSE overview →